N
NMRA
Neumora Therapeutics Inc
2.130
+0.010+0.47%After Hours: 2.130 0.000 0.00%16:10 04/07 EDT
OPEN/PREV CLOSE2.110/2.120
TODAY RANGE2.040-2.195
VOL1.30M
MARKET CAP387.75M
52 WEEK RANGE0.6110-3.650
AVG VOL (3M)1.39M
% TURNOVER0.72%
TURNOVER--
P/E (TTM)-1.4689
% RANGE7.31%
EPS(TTM)-1.4501
P/E(FORWARD)-2.2421
P/B3.573
BVPS0.5961
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP293.76M
SHARES OUTSTANDING182.04M
NEXT EARNINGS05/06-05/18
FREE FLOAT137.92M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Neumora Therapeutics management to meet with Piper Sandler
Seeking Alpha·6d ago
FuboTV and Yext are the most oversold among U.S. small-cap stocks
TipRanks·6d ago
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
Dow Jones·03/31 13:24
Neumora Therapeutics Price Target Maintained With a $14.00/Share by Guggenheim
Benzinga·03/31 13:15
Guggenheim Reiterates Buy on Neumora Therapeutics, Maintains $14 Price Target
TipRanks·03/31 11:02
Neumora Therapeutics, Inc. (NMRA) Gets a Buy from Guggenheim
Dow Jones·03/31 10:43
Neumora Therapeutics Price Target Maintained With a $8.00/Share by Needham
Benzinga·03/31 10:33
Needham Reiterates Buy on Neumora Therapeutics, Maintains $8 Price Target
Same Industry
Name/Symbol
Change%
Price